These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12476867)

  • 1. Spherical crystallization of celecoxib.
    Paradkar AR; Pawar AP; Chordiya JK; Patil VB; Ketkar AR
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1213-20. PubMed ID: 12476867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
    Gupta VR; Mutalik S; Patel MM; Jani GK
    Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
    Pandey S; Patil AT
    Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M
    Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of glassy celecoxib.
    Paradkar AR; Chauhan B; Yamamura S; Pawar AP
    Drug Dev Ind Pharm; 2003 Aug; 29(7):739-44. PubMed ID: 12906331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
    Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
    AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique.
    Pawar A; Paradkar A; Kadam S; Mahadik K
    AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
    Dalvadi H; Parmar K; Yadav S
    Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.
    Lakshmi K; Reddy MP; Kaza R
    Curr Drug Discov Technol; 2013 Dec; 10(4):305-14. PubMed ID: 24074306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
    Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
    Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and physicochemical and preclinical evaluations of recrystallized celecoxib.
    Mutalik S; Usha N; Ranjith AK; Umesh S; Musmade P; Anup N
    PDA J Pharm Sci Technol; 2007; 61(5):362-74. PubMed ID: 18047175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.
    Nasr M
    AAPS PharmSciTech; 2013 Jun; 14(2):719-26. PubMed ID: 23543607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
    Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of celecoxib porous particles using melt sonocrystallization.
    Paradkar A; Maheshwari M; Kamble R; Grimsey I; York P
    Pharm Res; 2006 Jun; 23(6):1395-400. PubMed ID: 16741659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.
    Tapas A; Kawtikwar P; Sakarkar D
    Acta Pol Pharm; 2012; 69(2):299-308. PubMed ID: 22568045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix.
    Jadhav N; Pawar A; Paradkar A
    AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.